Related Experiment Video
Updated: Jun 17, 2026

Assessing Hepatic Metabolic Changes During Progressive Colonization of Germ-free Mouse by 1H NMR Spectroscopy
Published on: December 15, 2011
Characterization of the Fecal Metabolome in Patients With Early Systemic Sclerosis
Arissa C Young1, Kristofer Andréasson2, Jennifer Labus1
1University of California, Los Angeles.
Objective:
To evaluate the fecal metabolome in patients with early systemic sclerosis (SSc) compared with unaffected controls and to determine if altered metabolites are associated with specific bacterial genera in patients with early SSc.
Methods:
Stool samples and clinical data were collected from 106 patients with early SSc and 79 unaffected control patients. Targeted metabolomics was performed on fecal samples using liquid chromatography mass spectrometry, and 16S ribosomal RNA gene sequencing was used to determine the microbial composition of fecal samples.
Results:
Compared with unaffected controls, patients with early SSc had higher levels of nicotinamide, 5'-methylthioadenosine, and several short-chain fatty acids (SCFAs) including valeric acid, propionic acid, and caproic acid. Conversely, patients with early SSc had lower levels of xylonic acid, orotate, methionine sulfoxide, and sarcosine. SCFAs were associated with unique bacterial genera, several of which were more abundant in patients with SSc compared with unaffected controls.
Conclusion:
The fecal metabolome is altered in patients with early SSc, with a shift toward increased SCFAs.
Related Concept Videos
Effect of Hepatic Disease on Pharmacokinetics: Pathophysiologic Assessment and Liver Function Test
Pharmacogenetics of Phase II Enzymes: N-acetyltransferase, Thiopurine S-methyltransferase, UDP-glucuronosyltransferase
Chronic Kidney Disease I: Introduction
Chronic Kidney Disease II: Clinical Manifestations
Peptic Ulcer Disease III: Clinical Manifestations and Complications
Jaundice

